Genes Chromosomes and Cancer · 2011 · 107 citations · 20 references
MedicineGeneticsOncologyCancer GeneticsGynecologic OncologyMolecular OncologyApoptosis In CancerCancer Survival AnalysisMalignant NeoplasmsOncogenic Signaling PathwaysOvarian CancerOvarian NeoplasiaArray Comparative Genomic HybridizationCopy Number Alteration AnalysisPhosphatidylinositol 3-Kinase-akt PathwayPi3 Kinase-akt SignalingPi3k SignalingPi3k-akt Signaling PathwayPik3ca MutationsSerous Ovarian Tumors
Identification and characterization of underlying genetic aberrations could facilitate diagnosis and treatment of ovarian cancer. Copy number analysis using array Comparative Genomic Hybridization (aCGH) on 93 primary ovarian tumors identified PI3K/AKT pathway as the most frequently altered cancer related pathway. Furthermore, survival analyses to correlate gene copy number and mutation data with patient outcome showed that copy number gains of PIK3CA, PIK3CB, and PIK3R4 in these tumors were associated with decreased survival. To confirm these findings at the protein level, immunohistochemistry (IHC) for PIK3CA product p110α and p-Akt was performed on tissue microarrays from 522 independent serous ovarian cancers. Overexpression of either of these two proteins was found to be associated with decreased survival. Multivariant analysis from these samples further showed that overexpression of p-AKT and/or p110α is an independent prognostic factor for these tumors. siRNAs targeting altered PI3K/AKT pathway genes inhibited proliferation and induced apoptosis in ovarian cancer cell lines. In addition, the effect of the siRNAs in different cell lines seemed to correlate with the particular genetic alterations that the cell line carries. These results strongly support the utilization of PI3K pathway inhibitors in ovarian cancer. They also suggest identifying the specific component in the PI3K pathway that is genetically altered has the potential to help select the most effective therapy. Both mutation as well as copy number changes can be used as predictive markers for this purpose.
20
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Juha Kononen, Lukas Bubendorf, Anne Kallionimeni et al. · Nature Medicine · 1998 · 4.1K citations
High Frequency of Mutations of the <i>PIK3CA</i> Gene in Human Cancers
Yardena Samuels, Zhenghe Wang, Alberto Bardelli et al. · Science · 2004 · 3.4K citations
Circular binary segmentation for the analysis of array-based DNA copy number data
Adam B. Olshen, E. S. Venkatraman, R. Lucito et al. · Biostatistics · 2004 · 2.4K citations
John Welsh, Patrick P. Zarrinkar, Lisa M. Sapinoso et al. · Proceedings of the National Academy of Sciences · 2001 · 658 citations